Literature DB >> 15677339

The wild-type Ras: road ahead.

Arvind Singh1, A Pavani Sowjanya, Gayatri Ramakrishna.   

Abstract

The cellular Ras is known to play an important role in cellular proliferation mediated by growth factor receptor. Evidence also points to its role in growth arrest. Substantiated proof for growth-suppressive activity of wild-type Ras comes from studies that showed 1) loss of wild-type ras allele in tumors, 2) suppression of growth in cells transformed by oncogenic ras upon overexpression of wild-type Ras, and 3) up-regulation of Ras expression during postnatal development and following growth arrest of untransformed cells in culture. To understand the mechanism by which the wild-type Ras brings about these diverse actions, we evaluated its well-known role in actively proliferating cells and its less understood role in growth arrest. This led to the proposal that wild-type Ras in either GDP or GTP-bound state can antagonize the function of oncogenic Ras.-Singh, A., Sowjanya, A. P., Ramakrishna, G. The wild-type Ras: road ahead.

Entities:  

Mesh:

Year:  2005        PMID: 15677339     DOI: 10.1096/fj.04-2584hyp

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  22 in total

Review 1.  c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.

Authors:  Chenguang Wang; Yanhong Tai; Michael P Lisanti; D Joshua Liao
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

2.  Oncogenic Src requires a wild-type counterpart to regulate invadopodia maturation.

Authors:  Laura C Kelley; Amanda Gatesman Ammer; Karen E Hayes; Karen H Martin; Kazuya Machida; Lin Jia; Bruce J Mayer; Scott A Weed
Journal:  J Cell Sci       Date:  2010-10-27       Impact factor: 5.285

Review 3.  Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.

Authors:  Chenguang Wang; Michael P Lisanti; D Joshua Liao
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

Review 4.  Intersectin scaffold proteins and their role in cell signaling and endocytosis.

Authors:  Erika Herrero-Garcia; John P O'Bryan
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2016-10-12       Impact factor: 4.739

5.  Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies.

Authors:  Ramon Andrade de Mello; Dânia Sofia Marques; Rui Medeiros; António Mf Araújo
Journal:  World J Clin Oncol       Date:  2011-11-10

6.  Wild-type H- and N-Ras promote mutant K-Ras-driven tumorigenesis by modulating the DNA damage response.

Authors:  Elda Grabocka; Yuliya Pylayeva-Gupta; Mathew J K Jones; Veronica Lubkov; Eyoel Yemanaberhan; Laura Taylor; Hao Hsuan Jeng; Dafna Bar-Sagi
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

7.  K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth.

Authors:  Efterpi Dalpa; Victor Gourvas; Nikolaos Soulitzis; Demetrios A Spandidos
Journal:  Med Oncol       Date:  2016-12-09       Impact factor: 3.064

8.  Hypoxia activates the K-ras proto-oncogene to stimulate angiogenesis and inhibit apoptosis in colon cancer cells.

Authors:  Min Zeng; Hirotoshi Kikuchi; Maria S Pino; Daniel C Chung
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

9.  RasGRP1 overexpression in the epidermis of transgenic mice contributes to tumor progression during multistage skin carcinogenesis.

Authors:  Courtney T Luke; Carolyn E Oki-Idouchi; J Mark Cline; Patricia S Lorenzo
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

10.  Fast simultaneous detection of K-RAS mutations in colorectal cancer.

Authors:  Ya-Sian Chang; Kun-Tu Yeh; Tien-Jye Chang; Connie Chai; Hsiu-Chin Lu; Nicholas C Hsu; Jan-Gowth Chang
Journal:  BMC Cancer       Date:  2009-06-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.